Ryan Michael Sandoval, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sandoval’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A172231 · Current
Licensed to practise in California · since 2021 · expires 2027-04-30 · School of Medicine, International University of Ecuador (Uide).
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas BP10049998Physician-in-Training Permit · since 2014 · expires 2017-06-30Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$100,597
Medicare paid this office $100,597 for 1,538 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 113 | $26,145 | $159 |
| New patient visit (60+ min) | 76 | $14,679 | $193 |
| Long return visit (40+ min) | 56 | $10,744 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,024 | $8,213 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,945 | $204 |
See all 18 services
| Long return visit (40+ min) | 113 | $26,145 | $159 |
| New patient visit (60+ min) | 76 | $14,679 | $193 |
| Long return visit (40+ min) | 56 | $10,744 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,024 | $8,213 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $7,945 | $204 |
| New patient visit (60+ min) | 48 | $6,322 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,431 | $106 |
| Return visit (30+ min) | 37 | $4,239 | $115 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 163 | $3,475 | $21 |
| New patient visit (45+ min) | 15 | $2,250 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,213 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,978 | $141 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,455 | $104 |
| Return visit (30+ min) | 11 | $965 | $88 |
| Injection, perflutren lipid microspheres, per ml | 11 | $768 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $319 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $246 | $19 |
| Injection, dobutamine hydrochloride, per 250 mg | 19 | $123 | None |
Who their Medicare patients are
1,538 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 16% · Women 51% · Also on Medicaid 28% · Health risk score 2.09. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Chronic kidney disease 42% · Atrial fibrillation 41% · Heart failure 39% · Diabetes 38% · Depression 25% · Cancer 24% · COPD 18% · Dementia 17% · Stroke 16%.
The office billed $478,315, Medicare allowed $134,750 and paid $100,597; for 2,120 services of 26 kinds; $896 of it was for drugs given in the office and $99,701 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,538 | 2,120 | 75 | 2.09 | $478,315 | $100,597 |
| 2023 | 1,114 | 1,687 | 75 | 2.21 | $403,626 | $93,449 |
| 2022 | 420 | 588 | 75 | 1.76 | $119,675 | $14,547 |
| 2018 | 32 | 60 | 71 | 2.72 | $20,600 | $5,299 |
| 2017 | 38 | 76 | 68 | 3.23 | $35,005 | $6,882 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $16,544 | $105 |
| Long return visit (40+ min) | 66 | $12,777 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,659 | $153 |
| New patient visit (60+ min) | 72 | $10,495 | $146 |
| Long return visit (40+ min) | 61 | $9,477 | $128 |
| New patient visit (60+ min) | 44 | $9,107 | $207 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 729 | $6,446 | $7 |
| Hospital discharge day management, more than 30 minutes | 53 | $5,544 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,790 | $117 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 81 | $1,894 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,497 | $71 |
| Telehealth originating site facility fee | 22 | $516 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $275 | $21 |
2022: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $6,022 | $49 |
| New patient visit (60+ min) | 14 | $2,316 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 195 | $1,380 | $6 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,204 | $50 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 27 | $547 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $456 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 49 | $292 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $260 | $11 |
| Ultrasound of heart, follow-up | 11 | $207 | $19 |
2018: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,572 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $866 | $58 |
2017: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,475 | $83 |
Medicaid work
$25,018 in 2024
Medicaid paid $25,018 for 970 billed services this clinician did in 2024, up to 136 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 794 | $8,425 |
| New patient visit (60+ min) | 53 | $8,070 |
| Long return visit (40+ min) | 91 | $7,874 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 32 | $649 |
| 2024 | 970 | 4 | 136 | $25,018 |
| 2023 | 799 | 4 | 224 | $13,205 |
| 2022 | 401 | 2 | 84 | $3,599 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 712 | $7,489 |
| New patient visit (60+ min) | 29 | $2,880 |
| Long return visit (40+ min) | 45 | $2,599 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 13 | $237 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 319 | $1,818 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 82 | $1,781 |
Drugs they prescribed that Part D paid
$141,074
Pharmacies billed $141,074 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 829) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
718 generic and 111 brand-name prescriptions · $141,074 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 38 | $57,081 | $1,502 |
| Eliquis | 32 | $38,998 | $1,219 |
| Entresto | 13 | $16,135 | $1,241 |
| Rosuvastatin | 84 | $1,611 | $19 |
| Metoprolol | 115 | $1,584 | $14 |
See all 16 drugs
| Jardiance | 38 | $57,081 | $1,502 |
| Eliquis | 32 | $38,998 | $1,219 |
| Entresto | 13 | $16,135 | $1,241 |
| Rosuvastatin | 84 | $1,611 | $19 |
| Metoprolol | 115 | $1,584 | $14 |
| Atorvastatin | 106 | $914 | $9 |
| Ezetimibe | 40 | $634 | $16 |
| Spironolactone | 32 | $444 | $14 |
| Carvedilol | 39 | $422 | $11 |
| Amlodipine Besylate | 63 | $321 | $5 |
| Metoprolol | 35 | $306 | $9 |
| Isosorbide Mononitrate Er | 29 | $282 | $10 |
| Clopidogrel | 22 | $276 | $13 |
| Losartan | 28 | $271 | $10 |
| Furosemide | 19 | $195 | $10 |
| Hydrochlorothiazide | 26 | $39 | $2 |
Year by year
| 2024 | 829 | 176 | 0% (0) | 13% | $141,074 |
| 2023 | 372 | 101 | 0% (0) | 11% | $60,681 |
| 2022 | 12 | None | 0% (0) | None | $455 |
| 2019 | 61 | None | 0% (0) | None | $1,569 |
| 2018 | 30 | None | None | 0% | $631 |
| 2017 | 57 | 17 | None | None | $5,735 |
| 2016 | 99 | 23 | None | 16% | $4,535 |
| 2015 | 46 | 21 | None | None | $1,159 |
| 2014 | 34 | None | None | None | $1,885 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Eliquis | 22 | $24,703 | $1,123 |
| Metoprolol | 53 | $1,211 | $23 |
| Rosuvastatin | 35 | $978 | $28 |
| Atorvastatin | 35 | $535 | $15 |
| Isosorbide Mononitrate Er | 18 | $448 | $25 |
| Amlodipine Besylate | 25 | $286 | $11 |
| Losartan | 16 | $269 | $17 |
| Spironolactone | 19 | $246 | $13 |
| Metoprolol | 12 | $155 | $13 |
| Clopidogrel | 12 | $155 | $13 |
| Carvedilol | 16 | $119 | $7 |
| Furosemide | 15 | $109 | $7 |
2019: 2 drugs
| Metoprolol | 16 | $185 | $12 |
| Clopidogrel | 21 | $62 | $3 |
Money from drug and device companies
$125 in 2021
| 2021 | 1 | 2 | None | $125 |
| 2019 | 3 | 3 | None | $305 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Opticross | $125 | 2 payments
|
See all 2 published payments
| Boston Scientific | Meals · 2021-04-27 | Opticross | $22 |
| Boston Scientific | Meals · 2021-04-17 | Opticross | $103 |
See earlier years (2019)
2019: $305
| Boston Scientific | Watchman | $167 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $100 | 1 payment
|
| Abbott Laboratories | Optis Coronary Imaging System | $38 | 1 payment
|
Professional record
- NPI
- 1285053041
- Licence
- CA A172231, OR MD208537, TX BP10049998California A172231: Current · expires 2027-04-30Texas BP10049998: Permit Terminated
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-04-09
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 601 E 15th St, Austin, TX, 78701